|
|
||||||||
Department of Integrative Biology, Pharmacology, and Physiology, University of Texas Medical School, Houston, Texas, 77030
| |
ABSTRACT |
|---|
|
|
|---|
Cytochrome
c protein and mRNA are 300 and 100%
higher, respectively, in the soleus muscle (predominantly slow-twitch
oxidative) than the white vastus lateralis (predominately
fast-twitch glycolytic) muscle (W. W. Winder, K. M. Baldwin, and J. O. Holloszy. Eur. J. Biochem. 47:
461-467, 1974; M. M. Lai and F. W. Booth. J. Appl. Physiol. 69: 843-848, 1990). However,
the mechanisms controlling these differences in cytochrome
c mRNA are largely unknown. The present study employed direct plasmid injection techniques to determine
whether the proximal promoter (
726 to +610) of the rat somatic
cytochrome c gene was more active in
the soleus than in white vastus lateralis muscles in rats. No
difference between the soleus and white vastus lateralis muscles for
the activities of the
726,
631,
489,
326,
215,
159 and
149 cytochrome c promoters was noted. The results of
this study suggest that additional elements (outside of
726 to
+610) in the cytochrome c gene may be
required, or posttranscriptional regulation may account, for the higher
cytochrome c mRNA in the slow-twitch
oxidative muscle.
mitochondria; direct plasmid injections; muscle fiber types; oxidative capacity
| |
INTRODUCTION |
|---|
|
|
|---|
SKELETAL MUSCLE FIBER diversity may arise from the
commitment of distinct myoblast lineages during myogenesis (27).
However, the phenotypes of adult muscles in living animals are very
plastic because the quantity of muscle contraction regulates the
expression of most contractile protein isoforms and metabolic enzymes
(22, 34). Pette and Staron (22) have commented that future research should be directed at improving our understanding of the molecular basis for the functional specialization of phenotypic expression in
skeletal muscle fibers. One approach to understanding the molecular mechanisms that control muscle diversification and plasticity is to
identify the DNA-regulatory sequences that confer fiber type-specific
expression of contractile proteins and metabolic enzymes. Extensive
studies of troponin slow and fast genes have indicated that several
core sequences in the promoters, such as E-box, CCAC-box, and
MEF-2-like sequence, bind their cognate factors and these
transcriptional factor-DNA interactions determine fiber type diversity
(18). Others have found the E box and MEF-2 sequences in fiber type
elements of troponin I slow (4) and myosin heavy chain IIB promoters
(29). A more recent study showed that both the nuclear respiratory
factor 1 (NRF-1)-binding site and cAMP-response element (CRE) in the
326 cytochrome c promoter are
necessary and sufficient for the induction of its promoter activity in
electrically stimulated cardiomyocytes in serum-free media (36).
Because the same treatment (electrical stimulation) does not increase mitochondrial density in cultured myotubes (15, 25), it seemed necessary to learn whether the same promoter's elements confer the
fiber type-specific difference in cytochrome
c gene expression in adult skeletal
muscle. Moreover, because muscle cultures do not manifest the specific
properties of muscles in living animals (9), the identification of the
cis-acting sequences in the cytochrome
c promoter that confer fiber
specificity needs to be addressed by using a living animal.
In 1969, Gauthier (10) published electron micrographs that showed that
red muscle fibers were richer in mitochondria than were white fibers in
animals. The concentration of cytochrome c protein, a mitochondrial protein in
the respiratory chain, has been used to determine the mitochondrial
density and/or oxidative capacity in the skeletal muscle due to
its parallel changes with other mitochondrial oxidative enzymes in
animals (35) and its possible limiting role for electron transport
(12). Winder et al. (35) reported that cytochrome
c protein concentration was 3 and 12 nmol/g wet weight for the white vastus lateralis (predominantly fast-twitch glycolytic) and soleus (predominantly slow-twitch oxidative) muscles, respectively, in sedentary rats. The soleus and
white vastus lateralis muscles are recruited ~7 h/day and ~2
min/day, respectively, in sedentary rats according to Hennig and Lomo
(14). These data suggested that the cytochrome
c level in skeletal muscle could be
regulated, in part, by differences in the quantity of contractile
activities among various fiber types in the animal. Mechanistically,
the fourfold higher concentration of cytochrome
c protein in slow-twitch oxidative
muscle than in fast-twitch glycolytic muscles (17) may be contributed,
in part, by the twofold difference in cytochrome
c mRNA level. Therefore, it is very
important to know whether the cytochrome
c promoter's activity is higher in
the slow-twitch oxidative than in the fast-twitch glycolytic muscles
because this information would be the basis for future experiments to
generate transgenic mice lacking the fiber type-specific element in the
cytochrome c promoter. A recent advance in gene delivery, the direct plasmid injection technique, has
allowed the relatively rapid estimation of promoter activities in
striated muscles of living animals (2, 4, 13, 16, 20, 21, 24,
29-31), and such results provide a more rational basis for future
transgenic animal models (4). The present study was undertaken to
determine whether the
726 promoter of the rat somatic cytochrome
c gene was more active in the soleus muscle than in the white vastus lateralis muscle in the living animal
(6, 22).
| |
METHODS |
|---|
|
|
|---|
Animals. Female Sprague-Dawley rats, weighing 100-149 g, were obtained from Harlan (Houston) and housed under temperature-controlled (21°C) conditions with a 12:12-h light-dark cycle. Rat chow and water were provided ad libitum. Protocols were approved by the University of Texas Health Science Center Institutional Animal Welfare Committee.
Plasmids.
Rat somatic cytochrome c promoter
(pRC)-luciferase plasmids were constructed from pRC4-chloramphenicol
acetyltransferase (CAT) (8) and pGL2-Basic (Promega).
Briefly, the Xho
I-Hind III fragments containing the
rat cytochrome c 5'-regions were
inserted by T4 ligase into the 5.6-kb
Xho
I-Hind III fragment of pGL2-Basic. pRC-luciferase chimeric genes were constructed as follows: various deletion constructs of the 5'-rat somatic cytochrome
c promoter (from either
726,
631,
491,
326,
215,
159, or
146 to +610) (8), the luciferase-coding region, and the SV40
polyadenylation site and splice signal at the 3'-end in pGL2 were
ligated (Promega) (Fig. 1). Plasmid DNAs
were transformed in JM109 bacteria (Promega). The bacteria were grown
for 12 h in Luria-Bertani medium with moderate shaking at 37°C.
Plasmid DNAs were isolated and purified by using alkaline lysis with
differential polyethylene glycol precipitation and subsequent phenol
extractions (26).
|
Plasmid injections.
Rats were anesthetized with a mixture of ketamine (54 mg/ml), xylazine
(2.2 mg/ml), and acepromazine (3.5 mg/ml) injected intramuscularly into
the right gluteus muscle (1.4 ml/kg). All DNA deletional constructs
were injected on the same day. Two-centimeter incisions were made
lateral to the soleus muscle and to the white vastus lateralis muscles
so that these muscles could be directly visualized. We selected these
two muscles because they have a twofold difference in cytochrome
c mRNA (17) and are visually accessible to verify the injections. To compare cytochrome
c chimeric gene expression between the
soleus and white vastus lateralis muscles, 20 µl of double-distilled
water containing plasmid DNA cocktail [50 µg of chimeric
reporter gene and 50 µg of constitutive reporter gene Rous sarcoma
virus promoter driving CAT (pRSV-CAT)] were injected for each
muscle. In preliminary experiments, luciferase and CAT activities were
measured 4 days after injection of various amounts of DNA (0, 50, 100, or 200 µg for each construct; n = 4 for each dose) to determine linearity of injected plasmid. For the
fiber type experiments, 200 µg of each plasmid were injected. Either
4 days (linearity experiments) or 7 days (fiber type experiments) after
these injections, rats were again anesthetized. The entire soleus and
white vastus lateralis muscles were dissected, weighed, quickly cut
into seventeen ~3-mm3 pieces,
fast-frozen with a pair of Wollenberger tongs prechilled in liquid
nitrogen, and held at
80°C until homogenized.
Tissue homogenization. Each sample was placed on ice and 5 ml/g (1 ml minimum) of ice-cold homogenization buffer [(in mM) 25 Tris-phosphate, pH 7.8, 2 trans-1,2-diaminocyclohexane-N, N',N'-tetraacetic acid, 10% glycerol, 2 1,4-dithiothreitol, 1 phenylmethylsulfonyl fluoride, 1 EDTA, and 1 benzamidine as well as 10 µg/ml leupeptin, 10 µg/ml pepstatin, 1 µg/ml aprotinin] were added to each sample in a 15-ml polyethylene tube. The samples were homogenized at 4°C with a Polytron (Brinkman) at 70% of its maximal intensity with three 10-s intervals. After centrifugation at 4°C for 15 min at 15,000 g, the pellet fraction was discarded and the supernatant was used for luciferase and CAT assays. Assays for either CAT or luciferase were performed at the same time for all muscle samples
Luciferase assays.
Luciferase activity was assayed immediately after muscle homogenates
were obtained by using a previously described procedure (32) with
modification (2). Briefly, the reaction was started by addition of 20 µl of the homogenate to 100 µl luciferase reagent containing (in
mM) 20 tricine (pH 7.8), 1.07 (MgCO3)4Mg(OH)2
· 5H2O,
2.67 MgSO4, 0.1 EDTA, 0.53 ATP,
0.27 CoA, and 33.3 1,4-dithiothreitol as well as 0.47 µM luciferin.
Seventy seconds after the initiation of the reaction, light production
becomes stable and it was measured by using a Monolight model 2010 luminometer (Analytical Luminescence Laboratory) and integrated for the
next 10 s. Total luciferase activity was calculated in relative light
units after correction for the background, which was the value from the
uninjected control muscles.
CAT assays. Each muscle homogenate was assayed for CAT activity as previously described (11) with modification (1). Briefly, the reaction was initiated by adding 25 µl homogenate to 65 µl of reaction cocktail containing (in mM) 192.3 Tris · HCl (pH 7.8), 1.85 acetyl-CoA, and 3.77 14C-labeled chloramphenicol (53 µCi/mmol). The promoter activity in each muscle sample was calculated as relative luciferase activity, i.e., the ratio of luciferase to CAT activity. For each animal, the mean value was taken from the left and right hindlimbs for the soleus and white vastus lateralis muscles.
Statistics. To determine the linear correlation between the constitutive reporter gene activities and the amount of DNA injected, regression with replication analysis was performed and the P value was calculated by analysis of variance. P < 0.05 was interpreted as a significant linear relationship between DNA-injection dose and the reporter gene activity. Cytochrome c promoter activity values are expressed as means ± SE. A paired Student's t-test was used to determine whether differences between means from the soleus and white vastus lateralis muscles were significant at a P < 0.05 level.
| |
RESULTS |
|---|
|
|
|---|
Coinjection of pSV40-luciferase and pRSV-CAT into rat skeletal muscles was performed to determine the linearity of the injection procedure. Expression of luciferase driven by either the SV40 promoter or the RSV promoter was linear up to 200 µg of plasmid DNA injected into the tibialis anterior, lateral gastrocnemius, or quadriceps muscles (r = 0.74, P < 0.01 for luciferase and r = 0.65, P < 0.05 for CAT) (Fig. 1).
To determine the difference in the cytochrome c promoter activities among muscles with different inherent contractile activities, pRSV-CAT or plasmids containing various lengths of the cytochrome c promoter driving the luciferase reporter gene were coinjected into the more active soleus (predominantly slow-twitch oxidative fibers) and less active white vastus lateralis (predominantly fast-twitch glycolytic fibers) muscles. The CAT enzyme activities from the control plasmid, pRSV-CAT, were not significantly different between soleus and white vastus lateralis muscles (19.0 ± 2.3 vs. 14.9 ± 1.7% conversion/min, respectively; P > 0.05; n = 140). This result indicates that both the soleus and white vastus lateralis muscles have similar efficiency in taking up the pRSV-CAT plasmid DNA and expressing it, which, in addition to the above result of direct correlation between DNA dose and reporter gene activities, validated the use of pRSV-CAT as a control for DNA injection. There were variations in reporter gene activities from sample to sample, probably due to variations in plasmid DNA uptake by the muscle fibers (5). However, this error is diminished by correcting luciferase activity against its CAT activity from a constitutive promoter of a coinjected plasmid in the same muscle homogenate.
No differences in the
726,
631,
489,
326,
215,
159 and
149 cytochrome
c promoter activities, expressed as
relative luciferase activities, were noted between the soleus and white vastus lateralis muscles (Fig.
2). Because there were no significant differences in activity between the two muscles, we pooled
the data from the soleus and white vastus lateralis muscles to examine the deletion effect on the promoter activity (Fig. 2,
inset). Deletion from
726 to
489 did not markedly alter cytochrome
c activity. Deletion from
489
to
159 progressively reduced promoter activity. Deletion to
66 decreased promoter activity to the background of muscles
injected with promoterless constructs (data not shown). The major
difference with these data from a previous deletion study in cultured
kidney cells was that deletion of the regions containing the
5'-CRE site (
326/
215) in the cytochrome
c promoter region decreased the
promoter activity in skeletal muscle of the living rat but not in
cultured monkey kidney CV-1 cells (8). This difference might indicate
that the regions containing the 5'-CRE site and region I are
required for normal cytochrome c gene
expression in adult skeletal muscles, not in cultured kidney cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
No difference in the activities of the
726-bp cytochrome
c promoter or of its deletion
constructs has been found between rat skeletal muscles with greater and
lesser cytochrome c mRNA concentrations. The following options could explain these negative results. The first possibility is that higher cytochrome
c mRNA in the more active muscle is
not a consequence of more promoter activity for the cytochrome
c gene but is a result of greater mRNA
stability. However, Connor et al. (3) were unable to detect a half-life
for either cytochrome c oxidase
subunit III or VIc mRNA in skeletal muscle of living rats, so
determination of cytochrome c mRNA
half-life in muscles of living rats also seemed unfeasible. Furthermore, it is technically difficult to employ nuclear run-on (a
more direct measurement of transcription rate) for cytochrome c gene expression in the skeletal
muscles of living rats. For example, Neufer and Dohm (19) found that
the measured transcription rates of the cytochrome
c gene in skeletal muscle of control
and treadmill-run rats were too close to background level to report. In
the same muscles, GLUT-4 transcription rate was not only detectable but
shown to be elevated transiently postexercise (19). Thus nuclear run-on
assays for cytochrome c transcription
rate in rat skeletal muscle were also deemed not feasible in the
present study. If promoter activities are deemed as an index of
transcription rate, observations from the present report imply that
cytochrome c transcription is not
different between the soleus and white vastus lateralis muscles.
The second possibility for the lack of a difference in cytochrome
c promoter activity between muscles
with different cytochrome c mRNA
levels is that the methods employed in the present study failed to
detect a difference in promoter activities. However, we believe this
option is unlikely for the following reasons. Others have detected
electrically responsive regulatory elements within
726 to +610
of this promoter in cultured cardiomyocytes. Two elements [the
NRF-1 motif and CRE, which are located within
326 to +610 bp of
the cytochrome c promoter] were
shown to be necessary and sufficient for the induction of the
cytochrome c promoter in electrically
stimulated cardiomyocytes that had been cultured in serum-free media
(36). In contrast, our study showed that reporter genes bearing these
same elements were not activated by the inherently higher contractile
activity of the soleus muscle (compared with the white vastus lateralis
muscle) in living rats. One potential interpretation is that this
discrepancy could be the result of differences in gene regulation
pathways between the cardiac myocytes and skeletal muscle cells. If
this is true, then a signaling pathway of electrical stimulation to the
activation of the cytochrome c
promoter via NRF-1 and CRE sites in embryonic cardiomyocytes is missing
in the skeletal muscle of young rats. Another potential interpretation
for the differences between the previous and present study is that
cytochrome c promoter regulation differs between cultured cells and living animals. Precedence for this
possibility exists. For example, electrical stimulation of skeletal
myotubes in tissue culture (15, 25) did not result in an increase in
mitochondrial enzyme activities, whereas the indirect electrical
stimulation of skeletal muscle in the living animal resulted in very
large increases in mitochondrial proteins (33). Similar observations
have been made in developmental studies; Firulli and Olson (9) wrote
that it is becoming clear that significant discordances in gene
regulation often exist between cell culture and whole animals. A final
potential interpretation is that the fiber type and electrical activity
elements for the cytochrome c gene
differ.
The second methodological possibility for the lack of a difference in cytochrome c promoter activity between muscles with different cytochrome c mRNA levels is that the sensitivity of the technique employed is not suitable for detecting the difference in transcriptional rate. However, the standard error of the mean for promoter activity in the various cytochrome c deletion constructs in our present deletion experiments was 15 ± 2 relative luciferase light units (mean of 14 groups; 7 deletions tested in 2 muscles). Thus the methods employed appear to be sensitive enough to detect a difference between soleus and white vastus lateralis muscles when means differed by 35%, which is less than the twofold difference in cytochrome c mRNA. Moreover, others (2, 4, 13, 16, 20, 21, 24, 29-31) have been able to detect differences in promoter activities by using the direct injection of plasmids into striated muscles (Table 1).
|
Nevertheless, one limitation of the plasmid injection technique is that the expression of the coinjected reporter gene may be altered by the treatment independent of the reporter sequence. For example, if the activity in coinjected control plasmid increases with treatment, the corrected value of the reporter gene of interest will be artificially lowered as a result. In earlier studies an effect of the stretch-induced hypertrophy (2) on the expression of the reporter gene was noted. This limitation is not applicable to the present study because we did not find a significant difference with a large sample size (n = 140) in the constitutive promoter activities between the soleus and white vastus lateralis muscles.
In summary, regulatory regions responsible for the fiber type
differences in cytochrome c mRNA in
rat skeletal muscle may reside outside of the
726 to +610 region
of the gene, or it is posttranscriptional control that mediates the
upregulation of the cytochrome c gene
in the soleus, compared with the white vastus lateralis, muscle.
Modulation of cytochrome c gene
expression in various fiber types remains a complex problem in
exercising live animals.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Drs. Marc Hamilton, Martin Flück, Scott Gordon, Warren McClure, Chris Carlson, Brian Tseng, Ron Gomes, and Brian Pavey for discussions and thank Dr. Richard Scarpulla for pRC4CATs.
| |
FOOTNOTES |
|---|
This research was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-44208.
Present address of Z. Yan: Molecular Cardiology Laboratories, Div. of Cardiology, Dept. of Internal Medicine, 5323 Harry Hines Blvd., Univ. of Texas Southwestern Medical Center, Dallas, TX 75235-8573.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: F. W. Booth, Dept. of Integrative Biology and Pharmacology, Univ. of Texas Medical School, 6431 Fannin St., Houston, TX 77030.
Received 12 January 1998; accepted in final form 7 May 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Carson, J. A.,
R. J. Schwartz,
and
F. W. Booth.
SRF and TEF-1 control of chicken skeletal
-actin gene during slow-muscle hypertrophy.
Am. J. Physiol.
270 (Cell Physiol. 39):
C1624-C1633,
1996
2.
Carson, J. A.,
Z. Yan,
F. W. Booth,
M. E. Coleman,
R. J. Schwartz,
and
C. S. Stump.
Regulation of skeletal
-actin promoter in young chickens during hypertrophy caused by stretch overload.
Am. J. Physiol.
268 (Cell Physiol. 37):
C918-C924,
1995
3.
Connor, M. K.,
M. Takahashi,
and
D. A. Hood.
Tissue-specific stability of nuclear- and mitochondrially encoded mRNAs.
Arch. Biochem. Biophys.
333:
103-108,
1996[Medline].
4.
Corin, S. J.,
L. K. Levitt,
J. V. O'Mahoney,
J. E. Joya,
E. C. Hardeman,
and
R. Wade.
Delineation of a slow-twitch-myofiber-specific transcriptional element by using in vivo somatic gene transfer.
Proc. Natl. Acad. Sci. USA
92:
6185-6189,
1995
5.
Danko, I.,
J. D. Fritz,
S. Jiao,
K. Hogan,
J. S. Latendresse,
and
J. A. Wolff.
Pharmacological enhancement of in vivo gene expression in muscle.
Gene Ther.
1:
114-121,
1994[Medline].
6.
Delp, M. D.,
and
C. Duan.
Composition and size of type 1, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle.
J. Appl. Physiol.
80:
261-270,
1996
7.
Eckert, R. L.,
J. F. Crish,
E. B. Banks,
and
J. F. Welter.
The epidermis: genes on-genes off.
J. Invest. Dermatol.
109:
501-509,
1997[Medline].
8.
Evans, M. J.,
and
R. C. Scarpulla.
Both upstream and intron sequence elements are required for elevated expression of the rat somatic cytochrome c gene in COS-1 cells.
Mol. Cell. Biol.
8:
35-41,
1988
9.
Firulli, A. B.,
and
E. N. Olson.
Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity.
Trends Genet.
13:
364-369,
1997[Medline].
10.
Gauthier, G. F.
On the relationship of ultrastructural and cytochemical features to color in mammalian skeletal muscle.
Z. Zellforsch.
95:
462-482,
1969[Medline].
11.
Gorman, C. M.,
L. F. Moffat,
and
B. H. Howard.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol. Cell. Biol.
2:
1044-1051,
1982
12.
Gupte, S. S.,
and
C. R. Hackenbrock.
The role of cytochrome c diffusion in mitochondrial electron transport.
J. Biol. Chem.
263:
5248-5253,
1988
13.
Hasegawa, K.,
S. J. Lee,
S. M. Jobe,
B. E. Markham,
and
R. N. Kitsis.
Cis-acting sequences that mediate induction of
-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction.
Circulation
96:
3943-3953,
1997[Medline].
14.
Hennig, R.,
and
T. Lomo.
Firing patterns of motor units in normal rats.
Nature
314:
164-166,
1985[Medline].
15.
Jacobs, A. E. M.,
A. A. G. M. Benders,
A. Oosterhof,
and
J. H. Veerkamp.
Effects of growth medium, electrical stimulation and paralysis on various enzyme activities in cultured rat muscle cells. Comparison with activities in rat muscles in vivo.
Int. J. Biochem.
24:
751-758,
1992[Medline].
16.
Kitsis, R. N.,
P. M. Buttrick,
E. M. McNally,
M. L. Kaplan,
and
L. A. Leinwand.
Hormonal modulation of a gene injected into rat heart in vivo.
Proc. Natl. Acad. Sci. USA
88:
4138-4142,
1991
17.
Lai, M. M.,
and
F. W. Booth.
Cytochrome c mRNA and
-actin mRNA in muscles of rats fed
-GPA.
J. Appl. Physiol.
69:
843-848,
1990
18.
Nakayama, M.,
J. Stauffer,
J. Cheng,
S. Banernjee-Basu,
E. Wawrousek,
and
A. Buonanno.
Common core sequences are found in skeletal muscle slow- and fast-fiber-type-specific regulatory elements.
Mol. Cell. Biol.
16:
2408-2417,
1996[Abstract].
19.
Neufer, P. D.,
and
G. L. Dohm.
Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle.
Am. J. Physiol.
265 (Cell Physiol. 34):
C1597-C1603,
1993
20.
Ojamaa, K.,
and
I. Klein.
Thyroid hormone regulation of alpha-myosin heavy chain promoter activity assessed by in vivo DNA transfer in rat heart.
Biochem. Biophys. Res. Commun.
179:
1269-1275,
1991[Medline].
21.
Parmacek, M. S.,
A. J. Vora,
T. Shen,
E. Barr,
F. Jung,
and
J. M. Leiden.
Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene.
Mol. Cell. Biol.
12:
1967-1976,
1992
22.
Pette, D.,
and
R. S. Staron.
Cellular and molecular diversities of mammalian skeletal muscle fiber types.
Rev. Physiol. Biochem. Pharmacol.
116:
1-76,
1990[Medline].
23.
Pette, D.,
and
R. S. Staron.
Mammalian skeletal muscle fiber type transitions.
Int. Rev. Cytol.
170:
143-223,
1997[Medline].
24.
Prigozy, T.,
K. Dalrymple,
L. Kedes,
and
C. Shuler.
Direct DNA injection into mouse tongue muscle for analysis of promoter function in vivo.
Somat. Cell Mol. Genet.
19:
111-122,
1993[Medline].
25.
Rösler, K. M.,
V. Askanas,
W. K. Engel,
and
A. Martinuzzi.
Effects of electrical stimulation and tetrodotoxin paralysis on expression of muscle-specific isozymes of four enzymes in aneurally cultured embryonic rat muscle.
Exp. Neurol.
97:
739-745,
1987[Medline].
26.
Sambrook, J.,
E. F. Fritsch,
and
T. Maniatis.
Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
27.
Stockdale, F. E.,
and
J. B. Miller.
The cellular basis of myosin heavy chain isoform expression during development of avian skeletal muscle.
Dev. Biol.
123:
1-9,
1987[Medline].
28.
Suzuki, H.,
Y. Hosokawa,
H. Toda,
M. Nishikimi,
and
T. Ozawa.
Common-protein binding sites in the 5'-flanking regions of human genes for cytochrome c1 and ubiquinone-binding protein.
J. Biol. Chem.
265:
8159-8163,
1990
29.
Swoap, S. J.
In vivo analysis of the myosin heavy chain IIB promoter region.
Am. J. Physiol.
274 (Cell Physiol. 43):
C681-C687,
1998
30.
Vincent, C. K.,
A. Gualberto,
C. V. Patel,
and
K. Walsh.
Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle.
Mol. Cell. Biol.
13:
1264-1272,
1993
31.
Von Harsdorf, R.,
R. J. Schott,
Y-T. Shen,
S. F. Vatner,
V. Mahdavi,
and
B. Nadal-Ginard.
Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals.
Circ. Res.
72:
688-695,
1993[Abstract].
32.
Wet, J. R. D.,
K. V. Wood,
M. DeLuca,
D. R. Hliniski,
and
S. Subramani.
Firefly luciferase gene: structure and expression in mammalian cells.
Mol. Cell. Biol.
7:
725-737,
1987
33.
Williams, R. S.,
M. Garcia-Moll,
J. Mellor,
S. Salmons,
and
W. Harlan.
Adaptation of skeletal muscle to increased contractile activity. Expression of nuclear genes encoding mitochondrial proteins.
J. Biol. Chem.
262:
2764-2767,
1987
34.
Williams, R. S.,
and
P. D. Neufer.
Regulation of gene expression in skeletal muscle by contractile activity.
In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Oxford Univ. Press, 1996, sect. 12, chapt. 25, p. 1124-1150.
35.
Winder, W. W.,
K. M. Baldwin,
and
J. O. Holloszy.
Enzymes involved in ketone utilization in different types of muscle: adaptation to exercise.
Eur. J. Biochem.
47:
461-467,
1974[Medline].
36.
Xia, Y.,
L. M. Buja,
R. C. Scarpulla,
and
J. B. McMillin.
Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation.
Proc. Natl. Acad. Sci. USA
94:
11399-11404,
1997
This article has been cited by other articles:
![]() |
T. Akimoto, B. S. Sorg, and Z. Yan Real-time imaging of peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha} promoter activity in skeletal muscles of living mice Am J Physiol Cell Physiol, September 1, 2004; 287(3): C790 - C796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Swoap, R. B. Hunter, E. J. Stevenson, H. M. Felton, N. V. Kansagra, J. M. Lang, K. A. Esser, and S. C. Kandarian The calcineurin-NFAT pathway and muscle fiber-type gene expression Am J Physiol Cell Physiol, October 1, 2000; 279(4): C915 - C924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boudreau-Lariviere, D. J. Parry, and B. J. Jasmin Myotubes originating from single fast and slow satellite cells display similar patterns of AChE expression Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R140 - R148. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |